Last reviewed · How we verify
Prevention of anaemia in premature babies
Approved treatments
- Neorecormon · Roche Registration Limited
Neorecormon works by binding to the erythropoietin receptor, mimicking the action of natural erythropoietin to stimulate red blood cell production. - Neorecormon · Centre Hospitalier Universitaire, Amiens
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of anaemia in premature babies patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of anaemia in premature babies treatment landscape brief
- Prevention of anaemia in premature babies treatment updates RSS
Frequently asked questions about Prevention of anaemia in premature babies
What drugs treat Prevention of anaemia in premature babies?
Tracked treatments include Neorecormon.
What is the treatment for Prevention of anaemia in premature babies?
Standard treatment for Prevention of anaemia in premature babies includes Neorecormon. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of anaemia in premature babies patent cliff · Prevention of anaemia in premature babies CI report
- Treatment: Neorecormon · Roche Registration Limited
- Treatment: Neorecormon · Centre Hospitalier Universitaire, Amiens
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing